Connexins are expressed in primary brain tumors and enhance the bystander effect in gene therapy

Neurosurgery

Volumn 44, Issue 2, 1999, Pages 361-369

  Estin, David ^a,b   Li, Mingwei ^a,b   Spray, David ^c   Wu, Julian K ^a,b  

^a TUFTS MEDICAL CENTER   (United States)

^b BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^c ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

Brain tumor; Connexin 26; Connexin 43; Gene therapy; Glioma; Herpes simplex virus thymidine kinase

Indexed keywords

CONNEXIN 26; CONNEXIN 43; GANCICLOVIR; GAP JUNCTION PROTEIN; VIRUS ENZYME;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; ASTROCYTOMA; BRAIN TUMOR; CELL COMMUNICATION; GENE THERAPY; GLIOBLASTOMA; GLIOMA; GLIOSARCOMA; HERPES SIMPLEX VIRUS; HUMAN; HUMAN TISSUE; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; MENINGIOMA; NONHUMAN; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; RAT;

ANIMALS; BLOTTING, WESTERN; BRAIN; BRAIN NEOPLASMS; CELL COUNT; CONNEXIN 43; CONNEXINS; EPILEPSY; GANCICLOVIR; GENE EXPRESSION; GENE THERAPY; HUMANS; IMMUNOHISTOCHEMISTRY; RATS; SIMPLEXVIRUS; THYMIDINE KINASE; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 0032929652     PISSN: 0148396X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006123-199902000-00068     Document Type: Article

References (40)

1. Barba D, Hardin J, Ray J, Gage FH: Thymidine kinase-mediated killing of rat brain tumors. J Neurosurg 79:729-735, 1993.
2. Barba D, Hardin J, Sadelain M, Gage FH: Development of anti-tumor immunity following thymidine kinase-mediated killing of experimental brain tumors. Proc Natl Acad Sci U S A 91:4348-4352, 1994.
3. Bi WL, Parysek LM, Warnick R, Stambrook PJ: In vitro evidence that metabolic cooperation is responsible for the bystander effect observed with HSV tk retroviral gene therapy. Hum Gene Ther 4:725-731, 1993.
4. Cattoretti G, Pileri S, Parravicini C, Becker MH, Poggi S, Bifulco C, Key G, D'Amato L, Sabattini E, Feudale E: Antigen unmasking on formalin-fixed, paraffin-embedded tissue sections. J Pathol 171: 83-98, 1993.
5. Chen SH, Shine HD, Goodman JC, Grossman RG, Woo SL: Gene therapy for brain tumors: Regression of experimental gliomas by adenovirus-mediated gene transfer in vivo. Proc Natl Acad Sci U S A 91:3054-3057, 1994.
6. Crumpacker CS: Ganciclovir. N Engl J Med 335:721-729, 1996.
7. Culver KW: Clinical applications of gene therapy for cancer. Clin Chem 40:510-512, 1994.
8. Culver KW: Gene therapy for malignant neoplasms of the CNS. Bone Marrow Transplant 18:S6-S9, 1996.
9. Culver KW, Ram Z, Wallbridge S, Ishii H, Oldfield EH, Blaese RM: In vivo gene transfer with retroviral vector-producer cells for treatment of experimental brain tumors. Science 256:1550-1552, 1992.
10. Dermietzel R, Spray DC: Gap junctions in the brain: Where, what type, how many and why? Trends Neurosci 16:186-192, 1993.
11. Dermietzel R, Hertberg E, Kessler JA, Spray DC: Gap junctions between cultured astrocytes: Immunocytochemical, molecular and electrophysiological analysis. J Neurosci 11:1421-1432, 1991.
12. Dermietzel R, Traub O, Hwang TK, Beyer E, Bennett MV, Spray DC: Differential expression of three gap junction proteins in developing and mature brain tissues. Proc Natl Acad Sci U S A 86:10148-10152, 1989.
13. Dilber MS, Abedi MR, Christensson B, Bjorkstrand B, Kidder GM, Naus CC, Gahrton G, Smith CI: Gap junctions promote the bystander effect of herpes simplex virus thymidine kinase in vivo. Cancer Res 57:1523-1528, 1997.
14. Elshami AA, Saavedra A, Zhan H, Kucharczuk JC, Spray DC, Fishman GI, Amin KM, Kaiser LR, Albelda SM: Gap junctions play a role in the bystander effect of the herpes simplex virus thymidine kinase/ganciclovir system in vitro. Gene Ther 3:85-92, 1996.
15. Fick J, Barker FG II, Dazin P, Westphale EM, Beyer EC, Israel MA: The extent of heterocellular communication mediated by gap junctions is predictive of bystander tumor cytotoxicity in vitro. Proc Natl Acad Sci U S A 92:11071-11075, 1995.
16. Fishman GI, Spray DC, Leinwand LA: Molecular characterization and functional expression of the human cardiac gap junction channel. J Cell Biol 111:589-598, 1990.
17. Freeman SM, Abboud CN, Whartenby KA, Packman CH, Koeplin DS, Moolten FL, Abraham GN: The "bystander effect": Tumor regression when a fraction of the tumor mass is genetically modified. Cancer Res 53:5274-5283, 1993.
18. Fujimoto WY, Subak-Sharpe JH, Seegmiller JE: Hypoxanthineguanine phosphoribosyltransferase deficiency: Chemical agents selective for mutant or normal cultured fibroblasts in mixed and heterozygote cultures. Proc Natl Acad Sci U S A 68:1516-1519, 1971.
19. Goliger JA, Paul DL: Expression of gap junction proteins C×26, C×31.1, C×37, and C×43 in developing and mature rat epidermis. Dev Dyn 200:1-13, 1994.
20. Haefliger JA, Bruzzone R, Jenkins NA, Gilbert DJ, Copeland NG, Paul DL: Four novel members of the connexin family of gap junction proteins: Molecular cloning, expression, and chromosome mapping. J Biol Chem 267:2057-2064, 1992.
21. Hamel W, Magnelli L, Chiarugi VP, Israel MA: Herpes simplex virus thymidine kinase/ganciclovir-mediated apoptotic death of bystander cells. Cancer Res 56:2697-2702, 1996.
22. Kolberg R: The bystander effect in gene therapy: Great, but how does it work? J NIH Res 6:62-64, 1994.
23. Mesnil M, Piccoli C, Tiraby G, Willecke K, Yamasaki H: Bystander killing of cancer cells by herpes simplex virus thymidine kinase gene is mediated by connexins. Proc Natl Acad Sci U S A 93: 1831-1835, 1996.
24. Micevych PE, Abelson L: Distribution of mRNAs coding for liver and heart gap junction proteins in the rat central nervous system. J Comp Neurol 305:96-118, 1991.
25. Moolten FL: Tumor chemosensitivity conferred by inserted herpes thymidine kinase genes: Paradigm for a prospective cancer control strategy. Cancer Res 46:5276-5281, 1986.
26. Nagy JI, Ochalski PA, Li J, Hertzberg EL: Evidence for the co-localization of another connexin with connexin-43 at astrocytic gap junctions in rat brain. Neuroscience 78:533-548, 1997.
27. Naus CC, Elisevich K, Zhu DJ, Belliveau D, Del Maestro RF: In vivo growth of C6 glioma cells transfected with connexin 43 cDNA. Cancer Res 52:4208-4213, 1992.
28. Nicolson GL, Gallick GE, Dulski KM, Spohn WH, Lembo TM, Tainsky MA: Lack of correlation between intercellular junctional communication, p21rasEJ expression, and spontaneous metastatic properties of rat mammary cells after transfection with c-H-rasEJ or neo genes. Oncogene 5:747-753, 1990.
29. Oldfield EH, Ram Z, Culver KW, Blaese RM, DeVroom HL, Anderson WF: Gene therapy for the treatment of brain tumors using intratumoral transduction with the thymidine kinase gene and intravenous ganciclovir. Hum Gene Ther 4:39-69, 1993.
30. Ram Z, Culver KW, Walbridge S, Blaese RM, Oldfield EH: In situ retroviral-mediated gene transfer for the treatment of brain tumors in rats. Cancer Res 53:83-88, 1993.
31. Ram Z, Culver KW, Walbridge S, Frank JA, Blaese RM, Oldfield EH: Toxicity studies of retroviral-mediated gene transfer for the treatment of brain tumors. J Neurosurg 79:400-407, 1993.
32. Ram Z, Walbridge S, Shawker T, Culver KW, Blaese RM, Oldfield EH: The effect of thymidine kinase transduction and ganciclovir therapy on tumor vasculature and growth of 9L gliomas in rats. J Neurosurg 81:256-260, 1994.
33. Shinoura N, Chen L, Ward MA, Kim YG, Larson JJ, Warnick RE, Simon M, Menon AG, Bi WL, Stambrook PJ: Protein and messenger RNA expression of connexin43 in astrocytomas: Implications in brain tumor gene therapy. J Neurosurg 84:839-846, 1996.
34. Tamura M, Shimizu K, Yamada M, Miyao Y, Hayakawa T, Ikenaka K: Targeted killing of migrating glioma cells by injection of HTK-modified glioma cells. Hum Gene Ther 8:381-391, 1997.
35. Vrionis FD, Wu JK, Qi P, Cano W, Cherington V: A more potent bystander cytocidal effect elicited by tumor cells expressing the herpes simplex virus-thymidine kinase gene than by fibroblast virus-producer cells in vitro. J Neurosurg 83:698-704, 1995.
36. Vrionis F, Wu JK, Qi P, Waltzman M, Cherington V, Spray DC: The bystander effect exerted by tumor cells expressing the herpes simplex virus thymidine kinase (HSVtk) gene is dependent on connexin expression and cell communication via gap junctions. Gene Ther 4:577-585, 1997.
37. Weizsaecker M, Deen DF, Rosenblum ML, Hoshino T, Gutin PH, Barker M: The 9L rat brain tumor: Description and application of an animal model. J Neurol 224:183-192, 1981.
38. Wu JK, Cano WG, Meylaerts SAG, Qi P, Vrionis F, Cherington V: Bystander tumoricidal effect in the treatment of experimental brain tumors. Neurosurgery 35:1094-1103, 1994.
39. Zhu D, Caveney S, Kidder GM, Naus CC: Transfection of C6 glioma cells with connexin 43 cDNA: Analysis of expression, intercellular coupling, and cell proliferation. Proc Natl Acad Sci U S A 88:1883-1887, 1991.
40. Zhu D, Kidder GM, Caveney S, Naus CC: Growth retardation in glioma cells cocultured with cells overexpressing a gap junction protein. Proc Natl Acad Sci U S A 89:10218-10221, 1992.